Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: Changes in relation to sex, aging and Alzheimer's disease

Brain Research

Volumn 988, Issue 1-2, 2003, Pages 84-96

  Ishunina, Tatjana A ^a,b   Van Heerikhuize, Joop J ^a   Ravid, Rivka ^a,c   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Aging; Alzheimer's disease; Androgen; Cell size; Estrogen receptor and ; Golgi apparatus size; Sex difference; Tuberomamillary nucleus

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SEX HORMONE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AROUSAL; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN NUCLEUS; CELL SIZE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GOLGI COMPLEX; HUMAN; IMMUNOCYTOCHEMISTRY; LEARNING; MALE; METABOLIC ACTIVATION; MOLECULAR SIZE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0142011167     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03347-X     Document Type: Article

References (84)

1. Adams M.M., Fink S.E., Shah R.A., Janssen W.G., Hayashi S., Milner T.A., McEwen B.S., Morrison J.H. Estrogen and aging affect the subcellular distribution of estrogen receptor-α in the hippocampus of female rats. J. Neurosci. 22:2002;3608-3614.
2. Airaksinen M.S., Paetau A., Paljarvi L., Reinikainen K., Riekkinen P., Suomalainen R., Panula P. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience. 44:1991;465-481.
3. Airaksinen M.S., Reinikainen K., Riekkinen P., Panula P. Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions. 33:1991;104-107.
4. Azcoitia I., Sierra A., Garcia-Segura L.M. Localization of estrogen receptor β-immunoreactivity in astrocytes of the adult rat brain. Glia. 26:1999;260-267.
5. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3:2002;433-442.
6. Behl C., Manthey D. Neuroprotective activities of estrogen: an update. J. Neurocytol. 29:2000;351-358.
7. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
8. Braak H., Braak E. Anatomy of the human hypothalamus (chiasmatic and tuberal region). Prog. Brain Res. 93:1992;3-14.
9. Brinton R.D. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn. Mem. 8:2001;121-133.
10. Brown R.E., Stevens D.R., Haas H.L. The physiology of brain histamine. Prog. Neurobiol. 63:2001;637-672.
11. Donahue J.E., Stopa E.G., Chorsky R.L., King J.C., Schipper H.M., Tobet S.A., Blaustein J.D., Reichlin S. Cells containing immunoreactive estrogen receptor-α in the human basal forebrain. Brain Res. 856:2000;142-151.
12. Fekete C.S., Strutton P.H., Cagampang F.R., Hrabovszky E., Kallo I., Shughrue P.J., Dobo E., Mihaly E., Baranyi L., Okada H., Panula P., Merchenthaler I., Coen C.W., Liposits Z.S. Estrogen receptor immunoreactivity is present in the majority of central histaminergic neurons: evidence for a new neuroendocrine pathway associated with luteinizing hormone-releasing hormone-synthesizing neurons in rats and humans. Endocrinology. 140:1999;4335-4341.
13. Fernandez-Guasti A., Kruijver F.P.M., Fodor M., Swaab D.F. Sex differences in the distribution of androgen receptors in the human hypothalamus. J. Comp. Neurol. 425:2000;422-435.
14. Frisch C., Hasenohrl R.U., Haas H.L., Weiler H.T., Steinbusch H.W.M., Huston J.P. Facilitation of learning after lesions of the tuberomamillary nucleus region in adult and aged rats. Exp. Brain Res. 118:1998;447-456.
15. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63:2001;29-60.
16. Gibson G.E., Sheu K.-F., Blass J.P., Baker A., Carlson K.C., Harding B., Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45:1988;836-840.
17. Gonatas N.K., Gonatas J.O., Stieber A. The involvement of the Golgi apparatus in the pathogenesis of amyotrophic lateral sclerosis, Alzheimer's disease, and ricin intoxication. Histochem. Cell Biol. 109:1998;591-600.
18. Green P.S., Simpkins J.W. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;93-98.
19. Greene R.A. Estrogen and cerebral blood flow: a mechanism to explain the influence of estrogen on the incidence and treatment of Alzheimer's disease. Int. J. Fertil. Womens Med. 45:2000;253-257.
20. Hayaishi O. Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Phil. Trans. R. Soc. Lond. B Biol. Sci. 355:2000;275-280.
21. Henderson V.W. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am. J. Med. 103:1997;11S-18S.
22. Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 54:2000;295-301.
23. Higuchi M., Yanai K., Okamura N., Meguro K., Arai H., Itoh M., Iwata R., Ido T., Watanabe T., Sasaki H. Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience. 99:2000;721-729.
24. Huston J.P., Wagner U., Hasenohrl R.U. The tuberomamillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav. Brain Res. 83:1997;97-105.
25. Inestrosa N.C., Marzolo M.P., Bonnefont A.B. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Mol. Neurobiol. 17:1998;73-86.
26. T.A. Ishunina, W. Kamphorst, D.F. Swaab, Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer's disease, Neurobiol. Aging (2003) in press.
27. Ishunina T.A., Kruijver F.P.M., Balesar R., Swaab D.F. Differential expression of estrogen receptor α and β immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J. Clin. Endocrinol. Metab. 85:2000;3283-3291.
28. Ishunina T.A., Salehi A., Hofman M.A., Swaab D.F. Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent. J. Neuroendocrinol. 11:1999;251-258.
29. Ishunina T.A., Swaab D.F. Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol. Aging. 22:2001;417-426.
30. T.A. Ishunina, D.F. Swaab, Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca: relation to sex and aging, Exp. Neurol. (2003) in press.
31. Ishunina T.A., Unmehopa U.A., van Heerikhuize J.J., Pool C.W., Swaab D.F. Metabolic activity of the human ventromedial nucleus neurons in relation to sex and ageing. Brain Res. 893:2001;70-76.
32. Ishunina T.A., Wouda J., Fisser B., Swaab D.F. Sex differences in estrogen receptor α and β expression in vasopressin neurons of the supraoptic nucleus in elderly and Alzheimer's disease patients: no relationship with cytoskeletal alterations. Brain Res. 951:2002;322-329.
33. Kallo I., Butler J.A., Barkovics-Kallo M., Goubillon M.-L., Coen C.W. Oestrogen receptor β-immunoreactivity in gonadotropin releasing hormone-expressing neurones: regulation by oestrogen. J. Neuroendocrinol. 13:2001;741-748.
34. Kim S.H., Cairns N., Fountoulakisc M., Lubec G. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci. Lett. 300:2001;41-44.
35. Kruijver F.P.M., Balesar R., Espila A.M., Unmehopa U.A., Swaab D.F. Estrogen receptor-α distribution in the human hypothalamus in relation to sex and endocrine status. J. Comp. Neurol. 454:2002;115-139.
36. F.P.M. Kruijver, R. Balesar, A.M. Espila, U.A. Unmehopa, D.F. Swaab, Estrogen-receptor-β distribution in the human hypothalamus: similarities and differences with ERα distribution, J. Comp. Neurol. (2003) in press.
37. Kruijver F.P.M., Fernadez-Guasti A., Fodor M., Kraan E.M., Swaab D.F. Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J. Clin. Endocrinol. Metab. 86:2001;818-827.
38. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36:1998;357-378.
39. Laine K., Palovaara S., Tapanainen P., Manninen P. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Clin. Pharmacol. Ther. 66:1999;602-608.
40. Li R., Shen Y., Yang L.B., Lue L.F., Finch C., Rogers J. Estrogen enhances uptake of amyloid β-protein by microglia derived from the human cortex. J. Neurochem. 75:2000;1447-1454.
41. Lintunen M., Hyytia P., Sallmen T., Karlstedt K., Tuomisto L., Leurs R., Kiianmaa K., Korpi E.R., Panula P. Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H3 receptor mechanisms. FASEB J. 15:2001;1074-1076.
42. Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., Swaab D.F. Activation of vasopressin neurons in aging and Alzheimer's disease. J. Neuroendocrinol. 6:1994;673-679.
43. Mazurkiewicz-Kwilecki I.M., Nsonwah S. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. Can. J. Physiol. Pharmacol. 67:1989;75-78.
44. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
45. Melton L. Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens, London, UK, September 1999. Trends Endocrinol. Metab. 11:2000;69-71.
46. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., Alves S.E. Ultrastructural evidence that hippocampal α estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429:2001;355-371.
47. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. J. Am. Med. Assoc. 283:2000;1007-1015.
48. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomamillary nucleus of patients with Alzheimer's disease. Neurosci. Lett. 151:1993;196-199.
49. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.A., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.
50. Panula P., Airaksinen M.S., Pirvola U., Kotilainen E. A histamine-containing neuronal system in human brain. Neuroscience. 34:1990;127-132.
51. Panula P., Karlstedt K., Sallmen T., Peitsaro N., Kaslin J., Michelsen K.A., Anichtchik O., Kukko-Lukjanov T., Lintunen M. The histaminergic system in the brain: structural characteristics and changes in hibernation. J. Chem. Neuroanat. 18:2000;65-74.
52. Panula P., Rinne J., Kuokkanen K., Eriksson K.S., Sallmen T., Kalimo H., Relja M. Neuronal histamine deficit in Alzheimer's disease. Neuroscience. 82:1998;993-997.
53. Panula P., Takagi H., Inagaki N., Yamatodani A., Tohyama M., Wada H., Kotilainen E. Histamine-containing nerve fibers innervate human cerebellum. Neurosci. Lett. 160:1993;53-56.
54. Passani M.B., Bacciottini L., Mannaioni P.F., Blandina P. Central histaminergic system and cognition. Neurosci. Biobehav. Rev. 24:2000;107-113.
55. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology. 54:2000;2212-2217.
56. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
57. Prelevic G.M., Jacobs H.S. Menopause and post-menopause. Bailliere's Clin. Endocrinol. Metab. 11:1997;311-340.
58. Reisberg B., Ferris S.H., DeLeon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatr. 139:1982;1136-1139.
59. Rinne J.O., Paljarvi L., Rinne U.K. Neuronal size and density in the human nucleus basalis of Meynert in Alzheimer's disease. J. Neurol. Sci. 79:1987;67-76.
60. Salehi A., Heyn S., Gonatas N.K., Swaab D.F. Decreased protein synthetic ability of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neurosci. Lett. 193:1995;29-32.
61. Salehi A., Lucassen P.J., Pool C.W., Gonatas N.K., Ravid R., Swaab D.F. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 59:1994;871-880.
62. Saper C.B. Hypothalamus. Paxinos G. The Human Nervous System. 1990;389-413 Academic Press, San Diego.
63. Savaskan E., Olivieri G., Meier F., Ravid R., Muller-Spahn F. Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res. 908:2001;113-119.
64. Schneider C., Risser D., Kirchner L., Kitzmuller E., Cairns N., Prast H., Singewald N., Lubec G. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer's disease. Neurosci. Lett. 222:1997;183-186.
65. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
66. Seidman S.N., Walsch B.T. Testosterone and depression in ageing men. Am. J. Geriatr. Psychiatry. 7:1999;18-33.
67. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
68. Simpson J., Yates C.M., Watts A.G., Fink G. Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 14:1988;381-393.
69. Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am. J. Psychiatry. 155:1998;1310-1318.
70. Swaab D.F. Neurobiology and neuropathology of the human hypothalamus. Bjorklund A., Hokfelt T. Handbook of Chemical Neuroanatomy. The Primate Nervous System. Vol. 13:1997;39-136 Elsevier, Amsterdam. Part 1.
71. Swaab D.F., Grundke-Iqbal I., Iqbal K., Kremer H.P.H., Ravid R., Van de Nes J.A.P. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res. 590:1992;239-249.
72. Swaab D.F., Jongkind J.F. The hypothalamic neurosecretory activity during the oestrous cycle, pregnancy, parturition, lactation, and after gonadectomy, in the rat. Neuroendocrinology. 6:1970;133-145.
73. Swaab D.F., Lucassen P.J., Salehi A., Scherder E.J.A., van Someren E.J.W., Verwer R.W.H. Reduced neuronal activity and reactivation in Alzheimer's disease. Prog. Brain Res. 117:1998;343-377.
74. Thomas T., Rhodin J. Vascular actions of estrogen and Alzheimer's disease. Ann. NY Acad. Sci. 903:2000;501-509.
75. Toran-Allerand C.D. Novel sites and mechanisms of oestrogen action in the brain. Novartis Found. Symp. 230:2000;56-69.
76. Trottier S., Chotard C., Traiffort E., Unmehopa U., Fisser B., Swaab D.F. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Res. 939:2002;52-64.
77. Van De Nes J.A.P., Kamphorst W., Ravid R., Swaab D.F. Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol. 96:1998;129-138.
78. Vermeulen A. Environment, human reproduction, menopause, and andropause. Environ. Health Perspect. 101:1993;91-100.
79. Wada H., Inagaki N., Yamatodani A., Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci. 14:1991;415-418.
80. Wagner C.K., Silverman A.J., Morrell J.I. Evidence for estrogen receptor in cell nuclei and axon terminals within the lateral habenula of the rat: regulation during pregnancy. J. Comp. Neurol. 392:1998;330-342.
81. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. A controlled study. Neurology. 54:2000;2061-2066.
82. Wise P.M. Estradiol: a protective factor in the adult brain. J. Pediatr. Endocrinol. Metab. 13:2000;1425-1429.
83. Yaffe K., Haan M., Byers A., Tangen C., Kuller L. Estrogen use, APOE, and cognitive decline; evidence of gene-environment interaction. Neurology. 54:2000;1949-1953.
84. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Maric D., Barker J.L., Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport. 12:2001;1919-1923.